Recently, we were excited to hear that Sanofi/AgaMatrix have received FDA clearance for the iBGStar , the first blood glucose monitor that connects directly to an Apple...

Although most blood glucose meters are theoretically able to upload test results to a computer, the reality can be a frustrating, time-consuming process. Different...

Blood glucose monitoring meets Apple’s iPhone: our own Adam Brown test drives Sanofi/AgaMatrix’s new tiny smartphone glucose monitor, the iBGstar…

Does how often you eat make your blood glucose worse? CDE Gary Scheiner explains…

A story of hope and inspiration, Not Dead Yet chronicles Phil Southerland’s life with diabetes and his time cycling with Team Type 1.

In December, Novo Nordisk announced that it will advance FIAsp, an ultra-rapid-acting version of Novolog (insulin aspart), directly into phase 3 trials in late 2013 (the...

Gary Scheiner shares how to make your blood glucose data work for you.

We like Practical Diabetology because it's straightforward, actionable, and smart — but, be warned, it's for physicians.

Kelly on a heated day at the FDA and why a new drug class could bring diabetes patients, doctors, and educators closer to personalized therapy.

Frequent and careful blood glucose monitoring is unquestionably useful for people who take insulin, but is monitoring necessary for all patients

What’s an SGLT-2 inhibitor and how does it work? Includes cool FAQ!

In June 2012, Medtronic held an Investor Conference to describe its upcoming products and expectations for the next five years. One of the biggest news items for...

Wireless, cell phone-enabled, and data-to-the-cloud glucose meters are a new trend in diabetes, evidenced by the recent launch of Sanofi’s iBGStar (see test drive in...

How can the FDA change its view on drug approvals to give patients access to better therapies?

Our trip to Orlando brings smart, actionable advice on preventing high and low blood sugars from diabetes guru and educator Mr. Gary Scheiner.

Visiting your healthcare team? Kerri Sparling highlights the right questions to ask.

The World Health Organization (WHO) recently released its World Health Statistics 2o12 report, compiling data from 194 countries. The report estimates that about 9% of...

How can we make better use of our test strips?

Touchscreen meets insulin pump in Tandem’s new t:slim.

In March 2013, Novo Nordisk launched Tresiba (insulin degludec) , its new once-daily basal insulin for type 1 and type 2 diabetes, in the UK and Denmark. Tresiba will be...